BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1780 related articles for article (PubMed ID: 30482160)

  • 21. BM-MSCs display altered gene expression profiles in B-cell acute lymphoblastic leukemia niches and exert pro-proliferative effects via overexpression of IFI6.
    Pan C; Hu T; Liu P; Ma D; Cao S; Shang Q; Zhang L; Chen Q; Fang Q; Wang J
    J Transl Med; 2023 Sep; 21(1):593. PubMed ID: 37670388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of disease.
    Vicente López Á; Vázquez García MN; Melen GJ; Entrena Martínez A; Cubillo Moreno I; García-Castro J; Orellana MR; González AG
    PLoS One; 2014; 9(1):e84496. PubMed ID: 24400095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors].
    Li F; Lyu J; Duan Y; Sun Y; Li D; Wang Y; Hu X; Xiao D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):891-6. PubMed ID: 25339324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue.
    Heo JS; Choi Y; Kim HS; Kim HO
    Int J Mol Med; 2016 Jan; 37(1):115-25. PubMed ID: 26719857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone Marrow Mesenchymal Stromal Cells from Clinical Scale Culture: In Vitro Evaluation of Their Differentiation, Hematopoietic Support, and Immunosuppressive Capacities.
    Fajardo-Orduña GR; Mayani H; Castro-Manrreza ME; Flores-Figueroa E; Flores-Guzmán P; Arriaga-Pizano L; Piña-Sánchez P; Hernández-Estévez E; Castell-Rodríguez AE; Chávez-Rueda AK; Legorreta-Haquet MV; Santiago-Osorio E; Montesinos JJ
    Stem Cells Dev; 2016 Sep; 25(17):1299-310. PubMed ID: 27462977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identical, similar or different? Learning about immunomodulatory function of mesenchymal stem cells isolated from various mouse tissues: bone marrow, spleen, thymus and aorta wall.
    Hegyi B; Sági B; Kovács J; Kiss J; Urbán VS; Mészáros G; Monostori E; Uher F
    Int Immunol; 2010 Jul; 22(7):551-9. PubMed ID: 20497958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
    Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A
    Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
    Xu M; Shaw G; Murphy M; Barry F
    Stem Cells; 2019 Jun; 37(6):754-765. PubMed ID: 30779868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells.
    Siegel G; Kluba T; Hermanutz-Klein U; Bieback K; Northoff H; Schäfer R
    BMC Med; 2013 Jun; 11():146. PubMed ID: 23758701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity.
    Johann PD; Vaegler M; Gieseke F; Mang P; Armeanu-Ebinger S; Kluba T; Handgretinger R; Müller I
    BMC Cancer; 2010 Sep; 10():501. PubMed ID: 20858262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome.
    Starc N; Li M; Algeri M; Conforti A; Tomao L; Pitisci A; Emma F; Montini G; Messa P; Locatelli F; Bernardo ME; Vivarelli M
    Cytotherapy; 2018 Mar; 20(3):322-334. PubMed ID: 29291917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased apoptosis and peripheral blood mononuclear cell suppression of bone marrow mesenchymal stem cells in severe aplastic anemia.
    Chao YH; Lin CW; Pan HH; Yang SF; Weng TF; Peng CT; Wu KH
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27247. PubMed ID: 29870142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of three-dimensional prospectively isolated mouse bone marrow mesenchymal stem/stromal cell aggregates on nanoculture plates.
    Obara C; Tomiyama K; Takizawa K; Islam R; Yasuda T; Gotoh T; Tajima K
    Cell Tissue Res; 2016 Oct; 366(1):113-27. PubMed ID: 27100525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroblastoma-secreted exosomes carrying miR-375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells.
    Colletti M; Tomao L; Galardi A; Paolini A; Di Paolo V; De Stefanis C; Mascio P; Nazio F; Petrini S; Castellano A; Russo I; Caruso R; Piga S; De Vito R; Pascucci L; Peinado H; Masotti A; Locatelli F; Di Giannatale A
    J Extracell Vesicles; 2020 Jun; 9(1):1774144. PubMed ID: 32922693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
    Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
    [No Abstract]   [Full Text] [Related]  

  • 39. Enrichment of neural-related genes in human mesenchymal stem cells from neuroblastoma patients.
    Rodriguez-Milla MA; Mirones I; Mariñas-Pardo L; Melen GJ; Cubillo I; Ramírez M; García-Castro J
    Int J Mol Med; 2012 Aug; 30(2):365-73. PubMed ID: 22641458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.
    Melief SM; Zwaginga JJ; Fibbe WE; Roelofs H
    Stem Cells Transl Med; 2013 Jun; 2(6):455-63. PubMed ID: 23694810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.